1. Home
  2. EVAX vs GRNQ Comparison

EVAX vs GRNQ Comparison

Compare EVAX & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • GRNQ
  • Stock Information
  • Founded
  • EVAX 2008
  • GRNQ 2013
  • Country
  • EVAX Denmark
  • GRNQ Malaysia
  • Employees
  • EVAX N/A
  • GRNQ N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • GRNQ EDP Services
  • Sector
  • EVAX Health Care
  • GRNQ Technology
  • Exchange
  • EVAX Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • EVAX 8.7M
  • GRNQ 8.9M
  • IPO Year
  • EVAX 2021
  • GRNQ 2018
  • Fundamental
  • Price
  • EVAX $2.62
  • GRNQ $1.08
  • Analyst Decision
  • EVAX Strong Buy
  • GRNQ
  • Analyst Count
  • EVAX 3
  • GRNQ 0
  • Target Price
  • EVAX $33.33
  • GRNQ N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • GRNQ 327.5K
  • Earning Date
  • EVAX 03-26-2025
  • GRNQ 03-27-2025
  • Dividend Yield
  • EVAX N/A
  • GRNQ N/A
  • EPS Growth
  • EVAX N/A
  • GRNQ N/A
  • EPS
  • EVAX N/A
  • GRNQ N/A
  • Revenue
  • EVAX $3,295,000.00
  • GRNQ $2,727,344.00
  • Revenue This Year
  • EVAX $4,845.21
  • GRNQ N/A
  • Revenue Next Year
  • EVAX $30.30
  • GRNQ N/A
  • P/E Ratio
  • EVAX N/A
  • GRNQ N/A
  • Revenue Growth
  • EVAX N/A
  • GRNQ N/A
  • 52 Week Low
  • EVAX $2.22
  • GRNQ $0.80
  • 52 Week High
  • EVAX $23.70
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • GRNQ 50.02
  • Support Level
  • EVAX $2.22
  • GRNQ $0.97
  • Resistance Level
  • EVAX $4.05
  • GRNQ $1.28
  • Average True Range (ATR)
  • EVAX 1.17
  • GRNQ 0.07
  • MACD
  • EVAX 0.00
  • GRNQ -0.00
  • Stochastic Oscillator
  • EVAX 6.99
  • GRNQ 60.42

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Share on Social Networks: